Information brève en Français
Rotavirus is the most common cause of severe diarrhoeal disease in infants and young children all over the world.
It is thought to cause about 125 million cases of diarrhoea and an estimated 500 000 deaths each year. It is highly infectious and is spread by the oral-faecal route.
Infants and young children who become infected with the virus suffer vomiting, fever and watery diarrhoea. Most cases are mild, but in severe cases, these symptoms will cause life-threatening dehydration if left untreated. Because infection is so common, most children will develop immunity to the virus within their first two to three years of life.
There are no appropriate drug treatments. Oral rehydration therapy helps to save the lives of infected children but does not prevent new infections. Therefore, a vaccine is needed. The first to be licensed was last year withdrawn from the market by its producer following large-scale surveillance in the United States because of a possible link with intussusception (a blockage of the intestine). Other vaccones against rotavirus are in development.
For more information on the GAVI Rotavirus ADIP project see:
The GAVI ADIPs section
Program for Appropriate Technology in Health (PATH)
For more information see
- CVP's Rotavirus Quick Facts
At a glance
Vaccine-preventable disease statistics
Glossaire des infections a prévention vaccinale
'Traditional' or 'basic' vaccines
- Haemophilus influenzae b (Hib)
- Hepatitis B
- Yellow fever
Vaccines that are expected to be available shortly
- Pneumococcus (Streptococcus pneumoniae)
- Meningococcal A/C conjugate
Vaccines for which more research is needed